SCHEMBL30396381

SCHEMBL30396381

CC1CCN1S(=O)(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3015868 0.83 PSEN1 (0.54)
SCHEMBL27326458 0.79
SCHEMBL27326454 0.79
SCHEMBL27326455 0.79
SCHEMBL27331348 0.75 SMYD3 (0.38)
SCHEMBL27326283 0.75 SMYD3 (0.38)
SCHEMBL27395214 0.75 SMYD3 (0.38)
SCHEMBL27326724 0.73 EPHX2 (0.33)
SCHEMBL13154406 0.73 EPHX2 (0.33)
SCHEMBL27326721 0.73 EPHX2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116096710-A 4-oxo-3, 4-dihydroquinazolinone compounds for the treatment of BRAF related diseases and disorders 阿雷生物药品公司 2023-05-09 CN disclosed